Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck May Face $2 Bil. Tax Bill; Medco Transactions Subject Of IRS Notice

Executive Summary

Merck is facing a potential $2 bil. back tax liability arising out of a "partnership transaction" tied to the 1993 Medco acquisition
Advertisement

Related Content

GSK Contests $5.2 Bil. Tax Bill After IRS Decision On Zantac Transfer Pricing
MERCK MARKET SHARE ON MEDCO FORMULARIES REACHES 12%, UP FROM 10%; MERCK WILL NOT BROADEN PRODUCT LINE TO MAINTAIN MARKET SHARE, CEO GILMARTIN TELLS NYSSA
MERCK MARKET SHARE ON MEDCO FORMULARIES REACHES 12%, UP FROM 10%; MERCK WILL NOT BROADEN PRODUCT LINE TO MAINTAIN MARKET SHARE, CEO GILMARTIN TELLS NYSSA
Advertisement
UsernamePublicRestriction

Register

PS043982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel